788
Participants
Start Date
September 16, 2020
Primary Completion Date
February 1, 2026
Study Completion Date
April 1, 2026
Modified natural cycle
This treatment protocol is defined as a modified natural cycle as the participant will be instructed to (1) administer human chorionic gonadotropin (hCG) to assist with timing of the embryo transfer and (2) supplement the luteal phase with a low dose of progesterone.
Programmed cycle
This protocol is designated as programmed because the endometrial development occurs only in association with administration of estradiol and progesterone. No ovulation occurs due to suppression of follicle development by the estradiol and the timing of the transfer is based on the number of days elapsed following initiation of exogenous progesterone.
University of Rochester, Rochester
University of Pennsylvania, Philadelphia
Shady Grove Fertility, Rockville
Johns Hopkins, Baltimore
West Virginia University Center for Reproductive Medicine, Morgantown
Atrium Health, Charlotte
Cleveland Clinic Foundation, Beachwood
Northwestern University, Chicago
University of Oklahoma, Oklahoma City
CARE Fertility, Bedford
Stanford University, Sunnyvale
University of California San Francisco, San Francisco
Fertility Institute of Hawaii, Honolulu
Yale, Orange
Boston IVF, Waltham
Lead Sponsor
JHSPH Center for Clinical Trials
OTHER